Cargando…

Age at onset as stratifier in idiopathic Parkinson’s disease – effect of ageing and polygenic risk score on clinical phenotypes

Several phenotypic differences observed in Parkinson’s disease (PD) patients have been linked to age at onset (AAO). We endeavoured to find out whether these differences are due to the ageing process itself by using a combined dataset of idiopathic PD (n = 430) and healthy controls (HC; n = 556) exc...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavelka, L., Rauschenberger, A., Landoulsi, Z., Pachchek, S., May, P., Glaab, E., Krüger, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363416/
https://www.ncbi.nlm.nih.gov/pubmed/35945230
http://dx.doi.org/10.1038/s41531-022-00342-7
_version_ 1784764924470231040
author Pavelka, L.
Rauschenberger, A.
Landoulsi, Z.
Pachchek, S.
May, P.
Glaab, E.
Krüger, R.
author_facet Pavelka, L.
Rauschenberger, A.
Landoulsi, Z.
Pachchek, S.
May, P.
Glaab, E.
Krüger, R.
author_sort Pavelka, L.
collection PubMed
description Several phenotypic differences observed in Parkinson’s disease (PD) patients have been linked to age at onset (AAO). We endeavoured to find out whether these differences are due to the ageing process itself by using a combined dataset of idiopathic PD (n = 430) and healthy controls (HC; n = 556) excluding carriers of known PD-linked genetic mutations in both groups. We found several significant effects of AAO on motor and non-motor symptoms in PD, but when comparing the effects of age on these symptoms with HC (using age at assessment, AAA), only positive associations of AAA with burden of motor symptoms and cognitive impairment were significantly different between PD vs HC. Furthermore, we explored a potential effect of polygenic risk score (PRS) on clinical phenotype and identified a significant inverse correlation of AAO and PRS in PD. No significant association between PRS and severity of clinical symptoms was found. We conclude that the observed non-motor phenotypic differences in PD based on AAO are largely driven by the ageing process itself and not by a specific profile of neurodegeneration linked to AAO in the idiopathic PD patients.
format Online
Article
Text
id pubmed-9363416
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-93634162022-08-11 Age at onset as stratifier in idiopathic Parkinson’s disease – effect of ageing and polygenic risk score on clinical phenotypes Pavelka, L. Rauschenberger, A. Landoulsi, Z. Pachchek, S. May, P. Glaab, E. Krüger, R. NPJ Parkinsons Dis Article Several phenotypic differences observed in Parkinson’s disease (PD) patients have been linked to age at onset (AAO). We endeavoured to find out whether these differences are due to the ageing process itself by using a combined dataset of idiopathic PD (n = 430) and healthy controls (HC; n = 556) excluding carriers of known PD-linked genetic mutations in both groups. We found several significant effects of AAO on motor and non-motor symptoms in PD, but when comparing the effects of age on these symptoms with HC (using age at assessment, AAA), only positive associations of AAA with burden of motor symptoms and cognitive impairment were significantly different between PD vs HC. Furthermore, we explored a potential effect of polygenic risk score (PRS) on clinical phenotype and identified a significant inverse correlation of AAO and PRS in PD. No significant association between PRS and severity of clinical symptoms was found. We conclude that the observed non-motor phenotypic differences in PD based on AAO are largely driven by the ageing process itself and not by a specific profile of neurodegeneration linked to AAO in the idiopathic PD patients. Nature Publishing Group UK 2022-08-09 /pmc/articles/PMC9363416/ /pubmed/35945230 http://dx.doi.org/10.1038/s41531-022-00342-7 Text en © The Author(s) 2022, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Pavelka, L.
Rauschenberger, A.
Landoulsi, Z.
Pachchek, S.
May, P.
Glaab, E.
Krüger, R.
Age at onset as stratifier in idiopathic Parkinson’s disease – effect of ageing and polygenic risk score on clinical phenotypes
title Age at onset as stratifier in idiopathic Parkinson’s disease – effect of ageing and polygenic risk score on clinical phenotypes
title_full Age at onset as stratifier in idiopathic Parkinson’s disease – effect of ageing and polygenic risk score on clinical phenotypes
title_fullStr Age at onset as stratifier in idiopathic Parkinson’s disease – effect of ageing and polygenic risk score on clinical phenotypes
title_full_unstemmed Age at onset as stratifier in idiopathic Parkinson’s disease – effect of ageing and polygenic risk score on clinical phenotypes
title_short Age at onset as stratifier in idiopathic Parkinson’s disease – effect of ageing and polygenic risk score on clinical phenotypes
title_sort age at onset as stratifier in idiopathic parkinson’s disease – effect of ageing and polygenic risk score on clinical phenotypes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363416/
https://www.ncbi.nlm.nih.gov/pubmed/35945230
http://dx.doi.org/10.1038/s41531-022-00342-7
work_keys_str_mv AT pavelkal ageatonsetasstratifierinidiopathicparkinsonsdiseaseeffectofageingandpolygenicriskscoreonclinicalphenotypes
AT rauschenbergera ageatonsetasstratifierinidiopathicparkinsonsdiseaseeffectofageingandpolygenicriskscoreonclinicalphenotypes
AT landoulsiz ageatonsetasstratifierinidiopathicparkinsonsdiseaseeffectofageingandpolygenicriskscoreonclinicalphenotypes
AT pachcheks ageatonsetasstratifierinidiopathicparkinsonsdiseaseeffectofageingandpolygenicriskscoreonclinicalphenotypes
AT mayp ageatonsetasstratifierinidiopathicparkinsonsdiseaseeffectofageingandpolygenicriskscoreonclinicalphenotypes
AT glaabe ageatonsetasstratifierinidiopathicparkinsonsdiseaseeffectofageingandpolygenicriskscoreonclinicalphenotypes
AT krugerr ageatonsetasstratifierinidiopathicparkinsonsdiseaseeffectofageingandpolygenicriskscoreonclinicalphenotypes
AT ageatonsetasstratifierinidiopathicparkinsonsdiseaseeffectofageingandpolygenicriskscoreonclinicalphenotypes